Using mindfulness to help cancer survivors quit smoking
Mindfulness-based ecological momentary intervention for smoking cessation among cancer survivors
This study is looking at how a mindfulness app can help cancer survivors quit smoking by giving them support and tools to handle triggers that make them want to smoke, making it easier for them to stay smoke-free.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11231965 on NIH RePORTER |
What this research studies
This research investigates how mindfulness-based interventions can support cancer survivors in quitting smoking by addressing both cancer-specific and general smoking triggers. It utilizes a mobile app to deliver real-time support, making it accessible and convenient for patients. The approach focuses on enhancing awareness and reducing reactivity to smoking cues, which is crucial for preventing relapse. By understanding the unique challenges faced by cancer survivors, this research aims to create a tailored intervention that meets their specific needs.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer survivors who currently smoke or have recently quit and are at risk of relapse.
Not a fit: Patients who do not smoke or have never smoked may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve smoking cessation rates among cancer survivors, leading to better health outcomes and quality of life.
How similar studies have performed: Previous research has shown that mindfulness-based interventions can be effective in promoting smoking cessation, particularly in populations with high stress levels, such as cancer survivors.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Yang, Min-Jeong — Rutgers Biomedical and Health Sciences
- Study coordinator: Yang, Min-Jeong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.